Please login to order a test.
- Jewish Heritage Test
If cultured cells are needed, an additional 7-12 days may be required. Additional culture fee may be included.
Expected Turnaround Time
7 - 14 days
Turnaround time is defined as the usual number of days from the date of pickup of a specimen for testing to when the result is released to the ordering provider. In some cases, additional time should be allowed for additional confirmatory or additional reflex tests. Testing schedules may vary.
Whole blood, amniotic fluid, chorionic villus sample (CVS) (Submission of maternal blood is required for fetal testing.), or LabCorp buccal swab kit (Buccal swab collection kit contains instructions for use of a buccal swab.)
7 mL whole blood, 10 mL amniotic fluid, 20 mg CVS, or LabCorp buccal swab kit
3 mL whole blood, 5 mL amniotic fluid, 10 mg CVS, or two buccal swabs
Lavender-top (EDTA) tube, yellow-top (ACD) tube, sterile plastic conical tube or two confluent T-25 flasks for fetal testing, or LabCorp buccal swab kit
Maintain specimen at room temperature or refrigerate at 4°C
Causes for Rejection
Frozen specimen; hemolysis; quantity not sufficient for analysis; improper container; one buccal swab; wet buccal swab
Detection of the c.1167insA mutation on the FKTN gene, which accounts for approximately 99% of Walker-Warburg carriers in the Ashkenazi Jewish population.
This test detects only the c.1167insA mutation
Polymerase chain reaction (PCR) and primer extension
Walker-Warburg syndrome (WWS, OMIM 236070) is an inherited, autosomal recessive disorder characterized by a triad of brain malformations, eye abnormalities, and congenital muscular dystrophy. The clinical findings include muscle weakness, hypotonia, feeding difficulties, blindness, seizures, and mal genital anomalies. Characteristic brain malformations include cobblestone lissencephaly, among other findings. Life expectancy is less than three years. The disease has an elevated prevalence in the Ashkenazi Jewish population, with a carrier rate of 1 in 150. When both parents are carriers of WWS, there is a 25% chance with each pregnancy of having a child with the disease. Prenatal diagnosis is available.
Molecular genetic testing for WWS encompasses one founder mutation in the gene encoding fukutin (FKTN gene, 9q31). Testing for the c.1167insA mutation identifies approximately 99% of WWS carriers in the Ashkenazi Jewish population. The carrier frequency in the non-Ashkenazi Jewish population has not been determined. A negative result decreases the likelihood that the individual is a carrier but cannot completely eliminate the possibility. The presence of a rare mutation cannot be ruled out. DNA test results must be combined with clinical information for the most accurate interpretation.
|Order Code||Order Code Name||Order Loinc||Result Code||Result Code Name||UofM||Result LOINC|
|511480||Walker-Warburg Syndrome||511481||Walker-Warburg Syndrome||53861-1|